Federal
Register Notices > Notice
of Registration - 2005 > Roche Diagnostics Operations Inc.
FR Doc 05-16568 [Federal Register: August 22, 2005 (Volume 70,
Number 161)] [Notices] [Page 48980] From the Federal Register Online
via GPO Access [wais.access.gpo.gov] [DOCID:fr22au05-108]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By notice dated April 25, 2005, and published in the Federal
Register on May 2, 2005, (70 FR 22704), Roche Diagnostics Operations
Inc., Attn: Regulatory Compliance, 9115 Hague Road, Indianapolis,
Indiana 46250, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in Schedules I and II:
Drug |
Schedule |
Lysergic Acid Diethylamide (7315) |
I |
Tetrahydrocannabinol (7370) |
I |
Alphamethadol (9605) |
I |
Phencyclidine (7471) |
II |
Benzoylecgonine (9180) |
II |
Methadone (9250) |
II |
Morphine (9300) |
II |
The company plans to manufacture small quantities of the listed
controlled substances for use in diagnostic products.
No comments or objections have been received. DEA has considered
the factors in 21
U.S.C. 823(a) and determined that the registration of Roche
Diagnostics Operations Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Roche Diagnostics Operations Inc. to
ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21
CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances
listed.
Dated: August 15, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. 05-16568 Filed 8-19-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|